Influenza: Vaccination
(asked on 12th July 2023) - View Source
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the Written Answer by Lord Markham on 22 June (HL8406), how many manufacturers of flu vaccinations they have identified to provide recommended vaccines to the UK for (1) those aged 65 and over, and (2) those aged 18 to 64 years in eligible groups; and how many manufacturing sites will each of those manufacturers use to supply the UK.
Adult flu vaccines are purchased locally by individual general practices and community pharmacies. A list of manufacturers of flu vaccines available for the 2023/4 season, including vaccine and age licensed from, was published alongside the annual flu letter, and is shown in the following table.
Vaccine | Manufacturer | Licensed from age |
Cell-based Quadrivalent Influenza Vaccine (QIVc) Egg-free | CSL Seqirus | licensed from 2 years of age |
Fluenz Tetra, live attenuated influenza vaccine (LAIV) | AstraZeneca | licensed from 2 years to under 18 years of age |
Quadrivalent Influenza Vaccine, egg-grown (QIVe) | Sanofi | licensed from 6 months of age |
Influvac sub-unit Tetra, Quadrivalent Influenza Vaccine, egg-grown (QIVe) | Viatris (formerly Mylan) | licensed from 6 months of age |
Supemtek, recombinant Quadrivalent Influenza Vaccine (QIVr) | Sanofi | licensed from 18 years of age |
Adjuvanted Quadrivalent Influenza Vaccine (aQIV) | CSL Seqirus | licensed from 65 years of age |
The Department does not hold information on where locally procured vaccines are manufactured.